European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- -

Monograph 0478 mandates several critical tests to ensure batch-to-batch consistency:

The (Tablets/Compressi) serves as the legally binding foundational standard for all tablet dosage forms in Europe. It ensures that regardless of the manufacturer, tablets meet consistent quality, safety, and efficacy requirements through rigorous manufacturing and testing protocols. Scope and Definitions European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

This ensures each tablet contains the correct amount of active ingredient. It often involves testing for Uniformity of Mass or Content. Monograph 0478 mandates several critical tests to ensure

The monograph mandates several standardized tests to verify the physical and chemical integrity of the dosage form. 1. Disintegration and Dissolution It often involves testing for Uniformity of Mass or Content

The European Pharmacopoeia (Ph. Eur.) Monograph 0478, (Compressi), defines the general quality, manufacturing, and testing standards for tablet preparations, including requirements for dissolution and mass uniformity. It specifies standards for various types, such as uncoated, coated, and gastro-resistant tablets, often requiring compliance with additional Ph. Eur. chapters. For the full text, see uspbpep.com

Mandatory for most solid dosage forms to confirm the active substance is released as intended.